BRIEF-GSK Announces Collaboration With CEPI To Develop Coronavirus Vaccine

BRIEF-GSK Announces Collaboration With CEPI To Develop Coronavirus Vaccine

GlaxoSmithKline PLC:

* GLAXOSMITHKLINE ANNOUNCES COLLABORATION WITH COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS (CEPI) TO DEVELOP CORONAVIRUS VACCINE​

* GSK SAYS WILL MAKE ITS 'ADJUVANT PLATFORM TECHNOLOGY' AVAILABLE IN AGREEMENT WITH CEPI TO SUPPORT DEVELOPMENT OF CORONAVIRUS VACCINES Source: http://bit.ly/2GQ5ERk Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.